BiopSee

What is important for us

Keeping people healthy with breakthrough medical technologies.

For more than 20 years MedCom offers innovative and advanced imaging-based products with emphasis on interventional/surgical navigation and cancer treatment solutions. MedCom developed the first commercially released “fusion imaging” with integrated intervention planning product for liver (2002) and prostate (2007). The MedCom’s fusion system BiopSee® has been CE released in 2011 and FDA in 2017 with numerous installations worldwide.

    • MedCom profile

      More information about our company and our BiopSee® product

      read more 

    • Product Locations

      BiopSee® installations worldwide

      read more